Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826

Lile Bennett Stuart Norman; Woolf Goldberg Frederick; Andrew Leach; Owen Whittamore Paul Robert; Pernilla Soerme

Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826

Lile Bennett Stuart Norman (Inventor), Woolf Goldberg Frederick (Inventor), Andrew Leach (Inventor), Owen Whittamore Paul Robert (Inventor), Pernilla Soerme (Inventor)

Pharmacy

AstraZeneca plc

Research output: Patent

Abstract

A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.

Original language	English
Patent number	US2011092526
IPC	C07D 239/ 47 A I
Priority date	19/10/10
Publication status	Published - 21 Apr 2011

Cite this

@misc{e09b394a9a9e45588a78a8315ec0b7e4,

title = "Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826",

abstract = "A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.",

author = "{Bennett Stuart Norman}, Lile and {Goldberg Frederick}, Woolf and Andrew Leach and {Whittamore Paul Robert}, Owen and Pernilla Soerme",

year = "2011",

month = apr,

day = "21",

language = "English",

type = "Patent",

note = "US2011092526; C07D 239/ 47 A I",

}

TY - PAT

T1 - Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826

AU - Bennett Stuart Norman, Lile

AU - Goldberg Frederick, Woolf

AU - Leach, Andrew

AU - Whittamore Paul Robert, Owen

AU - Soerme, Pernilla

PY - 2011/4/21

Y1 - 2011/4/21

N2 - A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.

AB - A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11βHSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.

M3 - Patent

M1 - US2011092526

ER -

Adamantyl Iminocarbonyl-Substituted Pyrimidines As Inhibitors Of 11-Beta-HSD1 826

Abstract

Fingerprint

Cite this